Literature DB >> 12819650

Infrapopliteal bypass reduces amputation incidence in elderly patients: a population-based study.

E Eskelinen1, M Luther, A Eskelinen, M Lepäntalo.   

Abstract

OBJECTIVE: To examine the association between the incidences of infrapopliteal bypass for critical limb ischaemia (CLI) and major amputation in Finns aged >or=70 years.
METHODS: Patients undergoing infrapopliteal bypass or major amputation for CLI during 1997 were retrospectively analysed. The incidence of major amputation in a group of hospitals performing infrapopliteal bypass "actively" was compared to that in a group performing such surgery "passively".
RESULTS: The incidence of major amputations in the active (978 bypasses per million inhabitants) and passive (57 per million) groups was 1976 and 3177 per million, respectively (p = 0.016). There was a significant (p = 0.012) inverse relationship between the incidence of the two procedures in patients aged >or=80, but not <80 years.
CONCLUSIONS: These results suggest that infrapopliteal bypass is effective in reducing the requirement for major amputation in patients aged >or=80 years.

Entities:  

Mesh:

Year:  2003        PMID: 12819650     DOI: 10.1053/ejvs.2002.1886

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

Review 1.  [Vascular surgery in the elderly].

Authors:  D Böckler; H Schumacher; J-R Allenberg
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

2.  Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study.

Authors:  Fausto Biancari; Juha-Pekka Salenius; Maarit Heikkinen; Michael Luther; Kari Ylönen; Mauri Lepäntalo
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

3.  Advanced leg salvage of the critically ischemic leg with major tissue loss by vascular and plastic surgeon teamwork: Long-term outcome.

Authors:  Erkki Tukiainen; M Kallio; M Lepäntalo
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.